Sources | Names Used |
---|---|
CTRPv2 | BRD-K09344309 |
PharmacoGx | BRD-K09344309 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PPP1R3C | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
mRNA | ABHD16B | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
mRNA | FRAT2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.08 |
mRNA | WDR49 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
mRNA | IGSF21 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
mRNA | ABHD17C | CTRPv2 | pan-cancer | AAC | 0.15 | 0.08 |
mRNA | METTL21B | CTRPv2 | pan-cancer | AAC | -0.17 | 0.08 |
mRNA | SPHAR | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
mRNA | IQGAP3 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.08 |
mRNA | NYX | CTRPv2 | pan-cancer | AAC | 0.17 | 0.08 |